Last update 23 Jun 2026

Shandong Fontacea Pharmaceutical Co., Ltd

Subsidiary Company|2019|Shandong Sheng, China|
www.fontaceapharma.com

Overview

Tags

Neoplasms
Skin and Musculoskeletal Diseases
Immune System Diseases
Bispecific antibody
Monoclonal antibody
Antibody drug conjugate (ADC)

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms4
Immune System Diseases1
Infectious Diseases1
Top 5 Drug TypeCount
Bispecific antibody3
Antibody drug conjugate (ADC)1
Monoclonal antibody1
Top 5 TargetCount
IL-17A(Interleukin 17A)1
HER2 x PDL11
PDL1 x SIRP1
LAG3 x PD-11
Trop-2(Tumor-associated calcium signal transducer 2)1

Related

5
Drugs associated with Shandong Fontacea Pharmaceutical Co., Ltd
HER2-PDL1
Target
HER2 x PDL1
Mechanism
HER2 modulators [+1]
Active Org.
Shandong Fontacea Pharmaceutical Co., Ltd
Originator Org.
Shandong Fontacea Pharmaceutical Co., Ltd
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
Trop2-adc(Shandong Fontacea Pharmaceutical)
Target
Trop-2
Mechanism
Trop-2 inhibitors
Active Org.
Shandong Fontacea Pharmaceutical Co., Ltd
Originator Org.
Shandong Fontacea Pharmaceutical Co., Ltd
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
SIRPα-PDL1
Target
PDL1 x SIRP
Mechanism
PDL1 inhibitors [+1]
Active Org.
Shandong Fontacea Pharmaceutical Co., Ltd
Originator Org.
Shandong Fontacea Pharmaceutical Co., Ltd
Active Indication
Neoplasms
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Shandong Fontacea Pharmaceutical Co., Ltd
CTR20231839
/ CompletedPhase 1
评估 FTC001在健康受试者中的安全性和耐受性的临床Ⅰ期研究
[Translation] Phase I clinical study to evaluate the safety and tolerability of FTC001 in healthy subjects
100 Clinical Results associated with Shandong Fontacea Pharmaceutical Co., Ltd
Login to view more data
0 Patents (Medical) associated with Shandong Fontacea Pharmaceutical Co., Ltd
Login to view more data
100 Deals associated with Shandong Fontacea Pharmaceutical Co., Ltd
Login to view more data
100 Translational Medicine associated with Shandong Fontacea Pharmaceutical Co., Ltd
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 12 Sep 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
5
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
CNTO-6785
 ( IL-17A )		Arthritis, Psoriatic
More
Preclinical
Trop2-adc(Shandong Fontacea Pharmaceutical)
 ( Trop-2 )		Neoplasms
More
Preclinical
HER2-PDL1
 ( HER2 x PDL1 )		Neoplasms
More
Preclinical
SIRPα-PDL1
 ( PDL1 x SIRP )		Neoplasms
More
Preclinical
LAG3-PD1 (Fontacea)
 ( LAG3 x PD-1 )		Neoplasms
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free